Colonic perforation after rituximab treatment for posttransplant lymphoproliferative disorder

Journal of Pediatric Gastroenterology and Nutrition

Volumn 56, Issue 6, 2013, Pages

  Kutsch, Erika ^a   Kreiger, Portia ^a   Consolini, Deborah ^b   Furuya, Katryn N ^a  

^a NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

^b Solid Organ Transplant ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RITUXIMAB; TACROLIMUS;

CASE REPORT; CHILD; COLON BIOPSY; COLON PERFORATION; COLON ULCER; COLONOSCOPY; DIAGNOSTIC IMAGING; DIGESTIVE SYSTEM EXAMINATION; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; EPSTEIN BARR VIRUS; FEMALE; GRANULATION TISSUE; HEART TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOPLASTIC LEFT HEART SYNDROME; IN SITU HYBRIDIZATION; INTESTINE RESECTION; LYMPHADENOPATHY; MAGNETIC RESONANCE ENTEROGRAPHY; MEDICAL HISTORY; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMERASE CHAIN REACTION; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE; PRESCHOOL CHILD; PRIORITY JOURNAL; RECTUM HEMORRHAGE; REPEAT PROCEDURE; RETROPERITONEAL LYMPHADENOPATHY; VIRUS GENOME;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC AGENTS; CHILD, PRESCHOOL; COLON, SIGMOID; FEMALE; GASTROINTESTINAL HEMORRHAGE; GRANULATION TISSUE; HEART TRANSPLANTATION; HUMANS; HYPOPLASTIC LEFT HEART SYNDROME; IMMUNOCOMPROMISED HOST; INTESTINAL PERFORATION; LYMPHOPROLIFERATIVE DISORDERS; POSTOPERATIVE COMPLICATIONS; SIGMOID DISEASES; TUMOR LYSIS SYNDROME;

EID: 84878950699     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0b013e3182519cfc     Document Type: Note

References (3)

1. Dodd GD,Greenler DP,Confer SR.Thoracic and abdominal manifestations oflymphomaoccurring in the immunocompromised patient. Radiol Clin NorthAm1992;30:597-610.
2. Kollmar O, Becker S, SchillingMK, et al. Intestinal lymphoma perforations as a consequence of highly effective anti-CD20 antibody therapy. Transplantation 2002;73:669-70.
3. Cornejo A, Bohnenblust M, Harris C, et al. Intestinal perforation associated with rituximab therapy for post-transplant lymphoproliferative disorder after liver transplantation. Cancer Chemother Pharmacol 2009;64:857-60.